REGENXBIO

Child jumping on trampoline

Biotech

Regenxbio reaps pivotal win for Duchenne gene therapy

The biotech is waiting to approach the FDA for approval until the dust settles at the agency.

Darren Incorvaia May 14, 2026 7:25am

step up climb ladder sky hang on rung

Regenxbio gene therapy passes interim test as pivotal data loom

Mar 12, 2026 5:49am

stack of letters mail envelopes

FDA details Regenxbio rare disease rejection

Mar 3, 2026 12:56pm

Image of a neon sign with the word no lit up next to an unlit yes

FDA rejects Regenxbio's Hunter syndrome gene therapy

Feb 9, 2026 4:05pm

Make a delay and accumulation of outstanding tasks Full stop

Brain tumor prompts FDA hold for 2 Regenxbio gene therapies

Jan 28, 2026 9:42am

clock delay wait time alarm

Regenxbio's Hunter gene therapy latest to face FDA delay

Aug 19, 2025 10:30am